Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-19 Sale |
2021-11-19 10:04 am |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
146,843 | $8.5 | $1,248,166 | 0 (Indirect Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 8:49 pm |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
3,944 | $6.45 | $25,439 | 146,362 (Indirect Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 5:56 pm |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
6,829 | $11.13 | $76,007 | 119,767 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 6:37 pm |
N/A 2035-02-27 |
Nuvation Bio Inc. | NUVB | Wentworth Kerry CHIEF REGULATORY OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:25 pm |
N/A 2034-02-27 |
Nuvation Bio Inc. | NUVB | Wentworth Kerry CHIEF REGULATORY OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:57 pm |
N/A 2033-02-27 |
Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-08-29 Option Award |
2022-08-31 5:18 pm |
N/A 2032-08-28 |
Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer |
252,000 | $0 | 252,000 (Direct) |
View |
| 2022-05-23 Option Award |
2022-05-25 4:36 pm |
N/A 2032-05-22 |
Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer |
577,500 | $0 | 577,500 (Direct) |
View |
Ownership |
2022-05-25 4:35 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Wentworth Kerry Chief Regulatory Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-28 6:09 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
539 | $7.78 | 150,306 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 6:35 pm |
N/A 2031-02-28 |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
50,000 | $0 | 169,767 (Direct) |
View |
| 2020-07-16 Option Award |
2020-07-20 9:23 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
38,750 | $0 | 126,180 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 4:09 pm |
N/A N/A |
Flexion Therapeutics Inc | FLXN | Wentworth Kerry Chief Regulatory Officer |
369 | $10.83 | 87,430 (Direct) |
View |